kabutan

Nippon Shinyaku Co.,Ltd.(4516) Summary

4516
TSE Prime
Nippon Shinyaku Co.,Ltd.
5,596
JPY
-200
(-3.45%)
Dec 12, 3:30 pm JST
35.92
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
5,561
Dec 12, 11:20 pm JST
Summary Chart Historical News Financial Result
PER
14.3
PBR
1.45
Yield
2.22%
Margin Trading Ratio
6.79
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
5,816 JPY 37.40 USD
Previous Close Dec 11
5,796 JPY 37.13 USD
High Dec 12, 9:00 am
5,841 JPY 37.56 USD
Low Dec 12, 2:37 pm
5,544 JPY 35.60 USD
Volume
919,400
Trading Value
5.20B JPY 0.03B USD
VWAP
5656.64 JPY 36.31 USD
Minimum Trading Value
559,600 JPY 3,592 USD
Market Cap
0.39T JPY 2.54B USD
Number of Trades
3,547
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
1,346
1-Year High Dec 8, 2025
46,428
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 48,800 410,800 8.42
Nov 28, 2025 45,500 330,800 7.27
Nov 21, 2025 49,500 329,700 6.66
Nov 14, 2025 68,000 383,300 5.64
Nov 7, 2025 61,700 422,700 6.85
Company Profile
Nippon Shinyaku Co., Ltd. primarily focuses on prescription pharmaceuticals, with strengths in urology and cardiovascular fields. The company also operates in the functional food business.
Sector
Pharmaceuticals
Nippon Shinyaku Co., Ltd. centers its operations on the pharmaceutical business, primarily targeting medical professionals, while also expanding into the functional food sector. In the pharmaceutical business, the company manufactures and sells its own products, and its subsidiary, Sioe Pharmaceutical Co., Ltd., also engages in manufacturing and sales. Tajima Food Co., Ltd. manufactures raw materials and supplies them to Nippon Shinyaku. Overseas, the U.S. subsidiary is responsible for pharmaceutical sales, out-licensing, and clinical development, while the Chinese subsidiary provides business support and sales services. In the functional food business, Nippon Shinyaku manufactures and sells its own products, with Tajima Food Co., Ltd. handling contract manufacturing. The company also receives product supplies from Sioe Pharmaceutical Co., Ltd. Furthermore, the subsidiary Nippon Shinyaku Advance Co., Ltd. provides business support, insurance agency services, real estate leasing, and educational support services.